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Keywords:
Avian inﬂuenza virusesKGX/53) and A/duck/Fujian/01/2002 (DKFJ/01) are H5N1 avian inﬂuenza viruses
that are lethal in chickens. In mice, however, DKFJ/01 is highly pathogenic, whereas DKGX/53 displays low
pathogenicity. In this study, we used reverse genetics to demonstrate that two amino acid residues at
positions 30 and 215 of the M1 protein of these two viruses are important determinants for pathogenicity in
mice. We thus ﬁrstly prove the M1 protein contributes to the virulence of H5N1 viruses in mice, and the
amino acid residues shown to attenuate the virulence could be targeted in inﬂuenza virus candidates for live
vaccine development.
© 2008 Elsevier Inc. All rights reserved.Introduction
H5N1 avian inﬂuenza outbreaks in poultry became widespread in
late 2003, initially affecting at least ten Asian countries. However,
since then, H5N1 avian inﬂuenza viruses have been isolated in wild
birds (Chen et al., 2006) and poultry in many countries throughout
Asia, Europe, and Africa (http://www.oie.int). Human cases of H5N1
infection have been reported in 14 countries (http://www.who.int),
and have resulted in greater than 50% mortality. The molecular basis
of the lethality of H5N1 avian inﬂuenza viruses in mammalian hosts
is still largely unknown, although previous studies have reported
that a basic amino acid stretch within the HA protein cleavage site
(Hatta et al., 2001), as well as speciﬁc amino acids in PB2 (Hatta et al.,
2001; Li et al., 2005) and NS1 (Jiao et al., 2008; Seo et al., 2002)
contribute to the lethality and host range of H5N1 viruses in mice
and pigs. A series of H5N1 inﬂuenza viruses isolated from healthy
ducks in southern China from 1999 through 2002 have been divided
into different pathotypes (ranging from nonpathogenic to highly
pathogenic) based on their replication and lethality in a mouse
model. These viruses were also divided into different genotypes
based on the genetic diversity of their internal genes (Chen et al.,
2004). Two viruses, A/duck/Guangxi/53/2002 (DKGX/53) and A/duck/
Fujian/01/2002 (DKFJ/01), are similar in their genome and although
are both highly lethal in chickens, they display very differentl rights reserved.lethalities in mice (Chen et al., 2004). DKGX/53 only replicates in
the lungs and has low pathogenicity in mice, whereas DKFJ/01
replicates systemically and is highly virulent in mice causing lethal
systemic infection (Chen et al., 2004). In this study, we selected these
two H5N1 viruses to explore the molecular basis of their virulence in
mice.
Results
We cloned cDNAs of each full-length RNA segment of the DKGX/
53 and DKFJ/01 viruses into a vRNA–mRNA bi-directional expression
plasmid pBD (Li et al., 2005) using a set of gene segment-speciﬁc
primers (sequences available upon request) as described previously
(Li et al., 2005). Using these plasmids, we rescued the DKGX/53 and
DKFJ/01 viruses, designated R-DKGX/53 and R-DKFJ/01, grew them
in 10-day-old, speciﬁc pathogen-free (SPF) embryonated chicken
eggs, and tested their replication and lethality in mice. As shown in
Table 1, the rescued R-DKGX/53 virus, like the wild-type DKGX/53,
only replicated in the lungs and killed only one mouse at the
highest inoculated viral dose. However, R-DKFJ/01 replicated
systemically and was as highly pathogenic as the original DKFJ/01
virus, with a 50% mouse lethal dose (MLD50) of 0.9 log10 50% egg
infectious doses (EID50).
These two viruses differ by only 28 amino acids in their genome
(Fig. 1). To identify the genes that contribute to virulence in mice, we
generated eight single-gene reassortants as described previously
(Hatta et al., 2001; Li et al., 2005), each containing one gene derived
from DKFJ/01 and seven genes derived from DKGX/53. We tested their
Table 1
Replication and lethality of viruses in micea
Virus Titer of stock
(log10 EID50)
Virus titers in organs on Day 3 p.i. (log10EID50±SD) b MLD50 (log10 EID50) f Change in MLD50
Lung Spleen Kidney Brain
DKGX/53c 7.5 4.2±0.3 − − − N6.5 NA
DKFJ/01c 9.5 7.4±0.3 3.2±0.2 2.4±0.5 1.2±0.3 b0.5 NA
R-DKGX/53 7.8 4.4±0.8 − − − 6.4 NA
R-DKFJ/01 9.2 7.0±0.1 2.0±0.9 2.4±0.2 1.4±0.5 0.9 NA
DKGX/53−FJ/01PB2 7.8 3.7±0.1 − − − 6.4 0g
DKGX/53–FJ/01PB1 7.5 4.1±0.2 − − − 6.4 0g
DKGX/53–FJ/01PA 7.5 4.1±0.5 − − − 6.4 0g
DKGX/53–FJ/01HA 8.3 4.1±0.6 − − − 6.4 0g
DKGX/53–FJ/01NP 8.0 4.1±0.3 − − − 6.4 0g
DKGX/53–FJ/01NA 9.3 5.8±0.3 − − − 6.4 0g
DKGX/53–FJ/01M 7.0 4.9±0.5 − − − 3.0 3.4g
DKGX/53–FJ/01NS 9.0 41±0.8 − − − 6.2 0.2g
DKFJ/01–GX/53PB2 9.7 6.1±0.4 1.3±0.4 − − 2.9 2h
DKFJ/01–GX/53PB1 9.3 6.1±0.1 1.1±0.5 1.0±0.8 + 2.5 1.6h
DKFJ/01–GX/53PA 8.2 5.3±0.4d 1.9±0.6 1.9±0.6 + 2.5 1.6h
DKFJ/01–GX/53HA 8.7 6.1±0.6 + + + 1.5 0.6h
DKFJ/01–GX/53NP 9.5 6.3±0.3 1.3±0.1 1.3±0.2d 1.3±0.2 1.5 0.6h
DKFJ/01–GX/53NA 7.5 6.5±0.5 − − − 0.9 0h
DKFJ/01–GX/53M 9.0 5.8±0.4d − − − 4.5 3.6h
DKFJ/01–GX/53NS 9.0 6.5±0.5 1.8±0.9 1.7±0.6 2.3±0.8 0.9 0h
Chimera 1 7.5 4.2±0.4 − − − 6.4 0g
Chimera 2 7.7 4.7±0.5 − − − 3.2 3.2g
DKGX/53M1N30D 7.5 4.6±0.9 − − − 5.8 0.6g
DKGX/53M1S126G 7.5 4.4±0.8 − − − 6.4 0g
DKGX/53M1T215A 7.7 4.6±0.1 − − − 4.6 1.8g
DKGX/53M1N30DT215A 7.3 4.0±0.4 − − − 3.2 3.2g
DKGX/53M1S126GT215A 7.5 4.6±0.7 − − − 4.3 2.1g
DKFJ/01M1D30NA215T 9.5 5.6±0.1e − − − 4.8 3.9h
DKFJ/01M1D30N 9.7 5.8±0.4d + 1.4±0.4 + 2.5 1.6h
DKFJ/01M1A215T 9.5 6.4±0.1d − + + 3.3 2.4h
a Six-week-old female BALB/c mice were used for these studies.
b Groups of threemicewere inoculated intranasally with 106 EID50 of the test virus in a 50 μl volume andwere killed on Day 3 post-inoculation (p.i.); organs were then collected for
virus titration in eggs. −, no virus was detected; +, virus was only detected from the undiluted samples.
c Data shown were from a previous study by Chen et al. (Chen et al., 2004).
d Pb0.05 compared with the titers in the corresponding organs of the DKFJ/01- or R-DKFJ/01-inoculated mice.
e Pb0.01 compared with the titers in the corresponding organs of the DKFJ/01- or R-DKFJ/01-inoculated mice.
f The 50% mouse lethal dose (MLD50) was determined by inoculating groups of ﬁve mice with 10-fold serial dilutions containing 101 to 106 EID50 of the virus in a 50 μl volume and
calculated by using the method of Reed and Muench (Reed, 1938).
g Virulence increased compared with the R-DKGX/53 virus.
h Virulence decreased compared with the R-DKFJ/01 virus.
29Rapid Communicationreplication and pathogenicity in mice as previously described (Chen et
al., 2004). Seven of the eight reassortant viruses only replicated in the
lungs and continued to display low pathogenicity in mice (MLD50 of
6.4 log10 EID50). Only the reassortant DKGX/53–FJ/01M that contained
the M gene of DKFJ/01 displayed high pathogenicity (MLD50 of 6.4
versus 3.0 log10 EID50). This reassortant was lethal in mice, but its
replication was restricted to the lungs (Table 1).
We then tested the effect of individual genes derived from DKGX/
53 on the replication and virulence of DKFJ/01. We generated 8
single-gene reassortant viruses, each containing one gene from
DKGX/53 and the remainder from DKFJ/01. The viruses that carried
the HA, NP, or NS gene of DKGX/53 were as virulent as DKFJ/01 and
replicated in all four organs tested (Table 1). The reassortant virus
DKFJ/01–GX/53NA was only detected in the lungs of infected mice,
but it killed mice at a low virus dose (MLD50 of 0.9 log10 EID50). The
reassortants that contained the PB2, PB1, or PA gene of DKGX/53
replicated in multiple organs (Table 1) but were less lethal than the
DKFJ/01 virus in mice (MLD50 of 2.5 to 2.9 log10 EID50). However,
introduction of the M gene of the DKGX/53 virus dramatically
attenuated the pathogenicity of DKFJ/01 by over 1000-fold [compare
MLD50 of DKFJ/01 (0.9 log10 EID50) with that of DKFJ/01–GX/53M (4.5
log10 EID50], and the reassortant virus only replicated in the lungs of
infected mice. The results of these reassortant virus experiments
indicate that multiple genes from the DKGX/53 virus could attenuate
the pathogenicity of the DKFJ/01 virus in mice, but that the M gene
contributed appreciably more to the virulence difference of the twoviruses in mice (Table 1). We therefore focused on the M gene for
further analyses.
The M proteins of the DKGX/53 and DKFJ/01 viruses differ by ﬁve
amino acids, three of which are located in the M1 protein and two in
the M2 protein (Fig. 1). To pinpoint the amino acid(s) in the DKFJ/01M
gene products that increase the virulence of the DKGX/53 virus in
mice, we generated two viruses that expressed chimeric M proteins
(Fig. 2) and tested them in mice. Chimera 1 (DKGX/53 virus
possessing the carboxy-terminal portion of the DKFJ/01M protein)
still displayed low pathogenicity in mice (MLD50 of 6.4 log10 EID50)
(Table 1, Fig. 2); however, Chimera 2 (DKGX/53 virus possessing the
amino-terminal portion of the DKFJ/01M protein) was much more
pathogenic than R-DKGX/53 (MLD50 of 3.2 log10 EID50 versus 6.4 log10
EID50) (Table 1, Fig. 2). These results indicate that the amino acid
differences in the M1 protein are responsible for the difference in
virulence between the DKGX/53 and DKFJ/01 viruses in mice.
The twoviruses differ byonly three amino acids in this region of the
M1 protein. To determine the respective importance of these residues
to the pathogenicity of these viruses inmice,we generated three single
amino acid mutant viruses in the DKGX/53 background (Fig. 2). The
mutant encoding an Asn-to-Aspmutation at position 30 ofM1 (DKGX/
53M1N30D) and the mutant encoding a Ser-to-Thr mutation at
position 126 of M1 (DKGX/53M1S126T) were not lethal in mice.
However, themutant encoding a Thr-to-Alamutation at position 215 of
M1 (DKGX/53M1T215A) killed mice at high doses, although the virus
was not as lethal as the reassortant virus DKGX/53FJ/01M1 or the
Fig. 1. Amino acid differences between the DKFJ/01 and DKGX/53 viruses. The amino
acid differences between the two viruses are shown as single letters: DKFJ/01 on the left
of the slash and DKGX/53 on the right. The M2 and NS2 areas are shown in gray.
Fig. 2. M1-mutant viruses and their virulence in mice. The bars show the origin of the
genes: white, DKGX/53; black, DKFJ/01. The amino acid differences between the M
protein of DKGX/53 and that of DKFJ/01 are shown as single letters with their positions
numbered at the top, and the mutated amino acids are shown in boldface italic. The 50%
mouse lethal dose (MLD50) was determined by inoculating groups of ﬁve mice with 10-
fold serial dilutions containing 101 to 106 EID50 of the virus in a 50 μl volume and
calculated by using the method of Reed and Muench (19).
30 Rapid Communicationchimera 2 (Table 1, Fig. 2), suggesting that one of the amino acids at
position 30 or 126may augment the increased virulence seenwith the
amino acid at position 215 in DKGX/53–FJ/01M1 or chimera 2 in mice.
We then generated two mutants encoding double mutations at
positions 30 and 215 of M1 (DKGX/53M1N30DT215A), or at positions
126 and 215 ofM1 (DKGX/53M1S126T T215A) and tested them inmice.
The mutant encoding the double mutations at positions 30 and 215 of
M1 (DKGX/52M1N30D/T215A) was as virulent as DKGX/53–FJ/01M1
or chimera 2 (MLD50 of 3.2 log10 EID50), but the virulence of themutant
encoding the double mutations at positions 126 and 215 of M1 was
similarwith that of the single amino acidmutant DKGX/53M1T215A in
mice (Table 1, Fig. 2).
To investigate the contributions of these two mutations to the
virulence of the DKFJ/01 virus, we generated 3 mutants in the DKFJ/01
background and tested them in mice. The viruses encoding the single
mutation at position 30 (DKFJ/01M1D30N) or position 215 (DKFJ/
01M1A215T) in the M1 proteinwere attenuated in mice 101.6 and 102.4
fold, respectively (Table 1, Fig. 2). However, the introduction of the
double mutations at positions 30 and 215 of the M1 protein markedly
attenuated DKFJ/01 pathogenicity (MLD50 of 0.9 log10 EID50 versus 4.8
log10 EID50) (Table 1, Fig. 2).
The amino acid at position 30 of M1 varies among inﬂuenza
viruses, most viruses (4697 of 4727 different subtype inﬂuenza viruses
isolated from different species, including humans) have Asp (D) at this
position, while 10 and 20 of 4727 viruses have Asn (N) and Gly (G),
respectively, at this position. There are no strong links between the
amino acid with animal species of which the viruses were isolated.
The amino acid at position 215 is quite conserved, 4725 of 4726 viruses
have Ala (A) at position 215, only the DKGX/53 virus has the amino
acid Thr (T) at position 215 in its M1. From available M1 sequence of
over 300 H5N1 inﬂuenza viruses, the amino acid Asn (N) at position 30
and Thr (T) at position 215 were only found in the DKGX/53 virus. To
test whether these two residues in DKGX/53 could attenuate other
highly pathogenic H5N1 viruses, we introduced them into the M1
gene of two other viruses, A/duck/Guangxi/35/01 (DKGX/35) and A/
duck/Guangxi/27/03 (DKGX/27), that are lethal in mouse and have
been described previously (Jiao et al., 2008; Li et al., 2005). We tested
the replication and virulence of the twomutants, DKGX/35–M1D30N/
A215Tand DKGX/27–M1D30N/A215T, inmice. As shown in Fig. 3A, the
wild type DKGX/35 replicated systemically and was highly lethal(MLD50 of 1.8 log10 EID50) (Fig. 3C), but the mutant DKGX/35–
M1D30N/A215T only replicated in the lungs of mice (Fig. 3A) and was
markedly attenuated (MLD50 of 6.4 log10 EID50) (Fig. 3D). Similarly, the
introduction of these two mutations markedly attenuated the DKGX/
27 virus, with the mutant DKGX/27–M1D30N/A215T only replicating
in the lungs and spleen of mice, and its virulence was 103.8 fold lower
than that of the DKGX/27 virus (MLD50 of 4.4 log10 EID50 versus 0.6
log10 EID50) (Figs. 3B, E, F).
Discussion
In conclusion, the results in this study demonstrate that the M1
protein contributes to the virulence of H5N1 avian inﬂuenza viruses in
a mammalian host. The amino acids Asp at position 30 and Ala at
position 215 in theM1 protein are necessary for H5N1 virus lethality in
mice. The M1 protein of inﬂuenza virus plays an essential role in viral
assembly, associating with inﬂuenza virus ribonucleoprotein (RNP)
and RNA (Baudin et al., 1994, 2001; Elster et al., 1997; Watanabe et al.,
1996; Ye et al., 1989, 1999), and functions in transcription inhibition
(Baudin et al., 1994; Elster et al., 1997; Wakeﬁeld and Brownlee, 1989;
Watanabe et al., 1996; Ye et al., 1989), and control of RNP nuclear
import and export (Bui et al., 1996; Huang et al., 2001; Martin and
Helenius, 1991; Wakeﬁeld and Brownlee, 1989; Watanabe et al., 1996;
Whittaker et al., 1995, 1996). Several studies have shown that mouse-
adapted inﬂuenza A and B viruses have uniquemodiﬁcations in a short
stretch of the C-terminal domain of their M1 protein (Brown et al.,
2001; Govorkova et al., 2000; Lee et al., 2001; McCullers et al., 2005;
Ward, 1997). Variations in the N-terminal and middle domains of the
M1 protein have also been associated with efﬁcient viral replication in
mouse lungs (Brown, 1990; Hui et al., 2006; Liu and Ye, 2005; Smeenk
and Brown, 1994). The amino acids at positions 30 and 215 identiﬁed
here as affecting virulence are found in the N-terminal and C-terminal
domains, respectively, of the M1 protein. Our results indicate that
mutation of these two amino acids has a cumulative effect on the
degree of virulence of H5N1 viruses in mice, although the underlying
mechanism remains to be determined. Our results further support the
concept that the pathogenicity of H5N1 inﬂuenza viruses is a polygenic
Fig. 3.Mutations in theM1 protein attenuate lethal H5N1 viruses. (A and B) Six-week-old SPF BALB/c mice (three/group) were inoculated intranasally with 106 EID50 of each virus in a
50 μl volume, killed on Day 3 post-inoculation (p.i), and their organs collected for virus titration in eggs. Data shown are the mean virus titers±standard deviation. The dashed line
indicates the limit of detection of the virus titers. (C–F) Survival curves of mice infected with DKGX/35 (C), DKGX/35–M1D30N/A215T (D), DKGX/27 (E) or DKGX/27–M1D30N/A215T
(F). Groups of ﬁve mice were inoculated with doses of 101 to 106 EID50 of virus in a 50 μl volume (101 EID50, ▴; 102 EID50, ●; 103 EID50, ♦; 104 EID50, Δ; 105 EID50, ○; 106 EID50, ◊).
31Rapid Communicationtrait, and thatmultiple domainswithin theM1 proteinmay be suitable
targets for the development of live vaccines.
Materials and methods
Cells and viruses
Human embryonic kidney cells (293T) and Vero cells were grown
in Dulbecco's modiﬁed Eagle's medium supplemented with 10% fetal
bovine serum plus antibiotics. The cells were incubated at 37 °C in 5%
CO2.
Construction of plasmids
The construction of plasmids for virus rescue was performed as
described previously (Li et al., 2005). Mutations were introduced intothe M1 gene by site-directed mutagenesis (Invitrogen) with the set of
primers (sequences available upon request).
Generation of reverse genetic reassortant viruses
Reassortant viruses were generated by reverse genetics as
described previously (Hatta et al., 2001; Li et al., 2005). The rescued
viruses were detected by hemagglutination assay, and RNA was
extracted and analyzed by reverse transcription-PCR (RT-PCR). Each
viral segment was sequenced to conﬁrm the identity of the
reassortant viruses.
Animal experiments
For the mouse study, groups of eight 6-week-old female BALB/c
mice (Beijing Experimental Animal Center) were lightly anesthetized
32 Rapid Communicationwith CO2 and inoculated intranasally with 106 EID50 of H5N1
inﬂuenza virus in a volume of 50 μl. Three mice in each group were
euthanized on Day 3 postinoculation (p.i.). Organs were collected and
titrated for virus infectivity in eggs as described previously (Chen et
al., 2004). The remaining mice were monitored for 14 days for weight
loss and mortality. The MLD50 was determined by inoculating groups
of ﬁve mice with 10-fold serial dilutions containing 101 to 106 EID50.
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